Viagra finds new off-label use treating women's circulation issues
The "little blue pill," FDA-approved for erectile dysfunction and pulmonary arterial hypertension, is being used by some women to combat the effects of Raynaud's syndrome.
Sildenafil, the active ingredient in Viagra, is increasingly being used off-label to treat a condition that causes poor circulation in extremities, affecting far more women than men.
While the medication is widely known for its approved use in treating erectile dysfunction, it has shown promise in alleviating symptoms of Raynaud's syndrome. This condition causes numbness, pain, and skin discoloration in the fingers and toes due to extreme reactions to cold temperatures. The body naturally constricts blood vessels in the extremities to preserve core temperature, but individuals with Raynaud's experience a more severe vascular spasm, leading to reduced blood flow.
Women are disproportionately affected by poor circulation and Raynaud's for several reasons. They naturally possess more body fat, which can restrict blood flow, and their smaller body size leads to faster heat loss. These factors contribute to their increased susceptibility to cold-related vascular issues.
The mechanism by which sildenafil aids in circulation is similar to its effect on erectile dysfunction. By promoting blood flow, the drug can help restore warmth and alleviate the painful symptoms associated with Raynaud's. Anecdotal evidence from bloggers and users on platforms like Reddit suggests that Viagra has been effective in reducing the frequency and severity of Raynaud's attacks.
However, it is important to note that sildenafil is not a first-line treatment for Raynaud's syndrome. Episodes typically resolve on their own with warming. Medical professionals advise minimizing cold exposure and using warm water to restore circulation. Prolonged attacks can lead to sores, tissue loss, and in rare cases, gangrene.
Physicians can legally prescribe sildenafil for off-label uses like Raynaud's at their discretion. One study indicated that sildenafil was effective in lowering the frequency and duration of Raynaud's attacks. The FDA has previously taken action against unauthorized products sold at gas stations that contained sildenafil, highlighting the importance of medical supervision due to potential drug interactions and risks of dangerously low blood pressure.